Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | POLB | P06746 | 4/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | CASP6 | P55212 | 1/20 | 0.50 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18962205 | 1.00 | ALDH1A1 (0.60) | ALDH1A1POLBTDP1MEN1KMT2A | |
| SCHEMBL16273350 | 0.83 | ALDH1A1 (0.44) | ALDH1A1POLBTDP1MEN1KMT2A | |
| SCHEMBL713506 | 0.82 | POLB (0.70) | ALDH1A1POLBTDP1MEN1KMT2A | |
| SCHEMBL381246 | 0.82 | POLB (0.70) | ALDH1A1POLBTDP1MEN1KMT2A | |
| SCHEMBL59471 | 0.82 | POLB (0.70) | ALDH1A1POLBTDP1MEN1KMT2A | |
| SCHEMBL24062391 | 0.82 | POLB (0.70) | ALDH1A1POLBTDP1MEN1KMT2A | |
| SCHEMBL20346210 | 0.82 | POLB (0.70) | ALDH1A1POLBTDP1MEN1KMT2A | |
| SCHEMBL1462188 | 0.82 | POLB (0.70) | ALDH1A1POLBTDP1MEN1KMT2A | |
| SCHEMBL23287488 | 0.82 | POLB (0.70) | ALDH1A1POLBTDP1MEN1KMT2A | |
| SCHEMBL14577505 | 0.82 | POLB (0.70) | ALDH1A1POLBTDP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12589157-B1 | Compositions of drug delivery agents and methods of use thereof | WASHINGTON UNIVERSITY (US) | 2026-03-31 | — | — | US | disclosed |
| US-10254645-B2 | Photosensitive resin composition, method for producing cured film, cured film, liquid crystal display device, organic electroluminescent display device, and touch panel | FUJIFILM CORPORATION (JP) | 2019-04-09 | — | — | US | disclosed |
| US-20170168391-A1 | PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR PRODUCING CURED FILM, CURED FILM, LIQUID CRYSTAL DISPLAY DEVICE, ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, AND TOUCH PANEL | FUJIFILM CORPORATION (JP) | 2017-06-15 | — | — | US | disclosed |
| US-20170168391-A1 | PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR PRODUCING CURED FILM, CURED FILM, LIQUID CRYSTAL DISPLAY DEVICE, ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, AND TOUCH PANEL | FUJIFILM CORPORATION (JP) | 2017-06-15 | — | — | US | disclosed |
| US-20160297921-A1 | CURABLE EPOXY COMPOSITION, FILM, LAMINATED FILM, PREPREG, LAMINATE, CURED ARTICLE, AND COMPOSITE | ZEON CORPORATION (JP) | 2016-10-13 | — | — | US | disclosed |
| US-20160257812-A1 | CURABLE EPOXY COMPOSITION, FILM, LAMINATED FILM, PREPREG, LAMINATE, CURED ARTICLE, AND COMPOSITE ARTICLE | ZEON CORPORATION (JP) | 2016-09-08 | — | — | US | disclosed |
| US-20150056434-A1 | CURABLE RESIN COMPOSITION, FILM, LAMINATED FILM, PREPREG, LAMINATE, CURED ARTICLE, AND COMPOSITE ARTICLE | ZEON CORPORATION (JP) | 2015-02-26 | — | — | US | disclosed |
| US-8057952-B2 | Polymer electrolyte membrane, method of manufacturing the same and fuel cell including the polymer electrolyte membrane | SAMSUNG SDI CO., LTD. (KR) | 2011-11-15 | — | — | US | disclosed |
| US-8057952-B2 | Polymer electrolyte membrane, method of manufacturing the same and fuel cell including the polymer electrolyte membrane | SAMSUNG SDI CO., LTD. (KR) | 2011-11-15 | — | — | US | disclosed |
| WO-2010001780-A1 | HEAT-RESISTANT RESIN PRECURSOR AND PHOTOSENSITIVE RESIN COMPOSITION COMPRISING THE SAME | 旭化成イーマテリアルズ株式会社 (JP) | 2010-01-07 | — | — | WO | disclosed |
| US-7416822-B2 | Resin and resin composition | ASAHI KASEI EMD CORPORATION (JP) | 2008-08-26 | — | — | US | disclosed |
| US-20070202375-A1 | Polymer electrolyte membrane, method of manufacturing the same and fuel cell including the polymer electrolyte membrane | SAMSUNG SDI CO., LTD. (KR) | 2007-08-30 | — | — | US | disclosed |
| US-20070202375-A1 | Polymer electrolyte membrane, method of manufacturing the same and fuel cell including the polymer electrolyte membrane | SAMSUNG SDI CO., LTD. (KR) | 2007-08-30 | — | — | US | disclosed |
| US-20070154843-A1 | Resin and resin composition | ASAHI KASEI EMD CORPORATION (JP) | 2007-07-05 | — | — | US | disclosed |
| US-20070154843-A1 | Resin and resin composition | ASAHI KASEI EMD CORPORATION (JP) | 2007-07-05 | — | — | US | disclosed |
| US-7049220-B2 | Method of forming cavity between multilayered wirings | JSR CORPORATION (JP) | 2006-05-23 | — | — | US | disclosed |
| US-20040132243-A1 | Method of forming cavity between multilayered wirings | JSR CORPORATION (JP) | 2004-07-08 | — | — | US | disclosed |
| EP-1416528-A2 | Method of forming cavity between multilayered wirings | JSR Corporation (JP) | 2004-05-06 | — | — | EP | disclosed |
| US-4176220-A | COORDINATION CATALYST | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1979-11-27 | — | — | US | disclosed |
| US-4068063-A | Catalyst composition for ring-opening polymerization of norbornene derivatives and process for polymerizing same | JAPAN SYNTHETIC RUBBER CO., LTD. (JA) | 1978-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12589157-B1 | Compositions of drug delivery agents and methods of use thereof | CALR, ABCC1, CALU | ALDH1A1 3670/4885POLB 4539/4885TDP1 4120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.